查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1745009

全球生物製藥物流市場

Bio-pharma Logistics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 231 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計2030年全球生物製藥物流市場規模將達1,729億美元

全球生物製藥物流市場規模預計在2024年為1,096億美元，到2030年將達到1,729億美元，在2024-2030年的分析期間內，複合年成長率為7.9%。低溫運輸物流是本報告分析的細分領域之一，預計其複合年成長率為6.4%，到分析期結束時規模將達到1042億美元。非低溫運輸物流領域在分析期間的複合年成長率預計為10.4%。

美國市場規模估計為 288 億美元，中國市場預計複合年成長率為 7.7%

2024年，美國生物製藥物流市場規模估計為288億美元。預計到2030年，作為世界第二大經濟體的中國市場規模將達到278億美元，在2024-2030年的分析期內，複合年成長率為7.7%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為7.0%和6.8%。在歐洲，預計德國市場的複合年成長率約為6.5%。

全球生物製藥物流市場－主要趨勢與促進因素摘要

為什麼生物製藥物流正在成為產品完整性、低溫運輸規性和全球治療範圍的戰略支柱？

生物製藥物流已發展成為生命科學價值鏈中一項關鍵任務，支持高價值藥品、生技藥品、疫苗以及細胞和基因治療產品的安全、及時、溫控配送。隨著產品複雜性和敏感性的不斷提高，物流如今在保障治療效果、法規遵循和市場准入方面發揮核心作用。從「第一英里」的原料藥運輸到「最後一哩路」的臨床交付，物流供應商正逐漸融入更廣泛的商業化和供應連續性策略。

隨著單株抗體、mRNA 疫苗和 CAR-T 療法等溫敏性生技藥品的興起，端對端低溫運輸物流的重要性日益凸顯。這些產品需要嚴格的溫度範圍（通常為 2-8°C、-20°C 或 -80°C 低溫儲存），並且必須即時監控，以防止可能影響產品活性的溫度超調。分散式臨床試驗、直接面向患者的配送模式以及全球疫苗項目的擴展，進一步提高了對物流基礎設施、可視性和可追溯性的需求。

除了溫度控制之外，生物製藥物流還必須應對與產品保存期限、法規協調、清關和運輸安全相關的挑戰。由於生技藥品和先進療法具有極高的經濟價值和治療價值，物流鏈中的任何中斷都可能對臨床和經濟造成重大影響。因此，製藥公司正在重新評估物流作為一項戰略能力，選擇合作夥伴時不僅要考慮成本，還要考慮品質保證、合規性以及技術準備。

低溫運輸技術、即時視覺性和風險緩解策略如何塑造生物製藥物流能力。

低溫運輸創新處於物流轉型的前沿。相變材料、真空隔熱包裝板和可重複使用的熱感運輸箱等先進包裝解決方案正在引入，以便在長時間運輸和各種氣候條件下保持溫度。採用乾蒸氣氮技術的低溫容器擴大用於運輸細胞和基因療法，在這些領域，超低溫的穩定性至關重要。

支援物聯網的數據記錄器、GPS 追蹤器和雲端基礎儀表板，提供位置、溫度、衝擊、光照和濕度的詳細洞察。這些工具使物流經理能夠在出現偏差時主動干預，轉移敏感貨物，並維護監管文件的審核線索。與倉庫管理系統 (WMS)、運輸管理系統 (TMS) 和基於區塊鏈的平台整合，進一步增強了可追溯性和監管鏈保障。

降低風險是生物製藥物流的首要任務，尤其是在高風險地區和疫情期間。緊急計畫、路線認證、雙供應商低溫運輸設定和冗餘儲存節點擴大被納入物流策略，以確保供應的連續性。 FDA、EMA 和 WHO 等監管機構正在對運輸驗證、溫度測繪和偏差響應通訊協定進行更嚴格的控制，這增加了對符合 GxP 營運和藥品級品質系統的物流合作夥伴的需求。

哪些治療領域、全球分銷網路和策略夥伴關係正在推動對專業生物製藥物流的需求？

細胞和基因療法、個人化癌症疫苗以及基於RNA的生技藥品等先進療法是生物製藥物流市場的主要成長要素。這些治療方法通常可行性有限，需要即時交付模式，並由擁有全球患者群體的集中式設施生產。免疫腫瘤學、罕見疾病、下一代疫苗等領域臨床試驗的激增，進一步增加了生技藥品在物流鏈中流通的數量和複雜性。

全球物流網路正在適應亞太、中東和拉丁美洲新興叢集的需求，這些集群正在擴大其生產和臨床試驗業務。為降低運輸風險並加快治療速度，這些集群正在策略性地建立配備GDP認證設施、區域冷藏和多模態的物流叢集。雖然北美和西歐仍然是中心樞紐，但製造的分散化和在地化正在推動向更敏捷、更分散的物流轉變。

製藥公司、第三方物流供應商、包裝供應商和技術賦能者之間的策略夥伴關係正在重新定義物流系統。路線檢驗通訊協定、共用風險模型和數位整合平台的共同開發，正在實現端到端的可視性和基於績效的物流管理。隨著製藥商轉向更精簡、需求主導的供應鏈，物流合作夥伴在規劃週期的早期就被納入其中，共同設計針對特定治療方案和監管途徑的解決方案。

生物製藥物流市場的成長要素是什麼？

隨著生命科學領域朝向複雜、溫度敏感且以患者為中心的治療方法發展，生物製藥物流市場也隨之擴張，這些療法需要精準且合規的物流解決方案。如今，物流已成為治療成功、病人安全和商業性擴充性的關鍵推動因素。

關鍵成長動力包括低溫運輸依賴型生技藥品和先進療法的普及、全球臨床臨床實驗的擴展、端到端可視性的監管要求，以及對分散式和敏捷交付模式日益成長的需求。技術創新、策略性外包和垂直整合的服務模式正在進一步加速市場的發展。

隨著生物製藥管道轉向更個人化、更高價值的療法，物流能否成為競爭優勢，從後端功能轉變為創造價值、降低風險並與創新保持一致的下一代藥物輸送的支柱？

部分

類型（低溫運輸物流、非低溫運輸物流）、服務類型（運輸、倉儲、包裝、其他服務類型）、應用（生技藥品、處方藥、非處方藥、原料/原料藥、其他應用）

調查企業範例（共42家企業）

  • Agility Logistics
  • Air Canada Cargo
  • AmerisourceBergen Corporation
  • Biocair
  • Cavalier Logistics
  • CEVA Logistics
  • DB Schenker
  • DHL Global Forwarding
  • FedEx Corporation
  • Kerry Logistics Network Limited
  • Kuehne+Nagel
  • LifeConEx
  • Marken（a UPS Company）
  • Nippon Express
  • SF Express
  • Sofrigam Group
  • United Parcel Service（UPS）
  • VersaCold Logistics Services
  • World Courier
  • Yusen Logistics

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口（成品和原始OEM）來預測其競爭地位的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括人為提高銷貨成本、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

全球產業分析師密切關注來自全球頂尖首席經濟學家（14,949位）、智庫（62家）以及貿易和產業協會（171家）的專家的意見，以評估其對生態系統的影響並應對新的市場現實。我們追蹤了來自每個主要國家的專家和經濟學家對關稅及其對本國影響的看法。

全球產業分析師預計，這場動盪將在未來2-3個月內逐漸平息，新的世界秩序將更加清晰地建立。全球產業分析師正在即時追蹤這些事態發展。

2025年4月：談判階段

在4月的報告中，我們將探討關稅對全球整體市場的影響，並提供區域市場調整。我們的預測是基於歷史數據和不斷變化的市場影響因素。

2025年7月：最終關稅調整

在各國宣布最終重置後，客戶將在 7 月收到免費更新，最終更新將包含明確的關稅影響分析。

相互和雙邊貿易及關稅影響分析：

美國<>中國<>墨西哥<>加拿大<>歐盟<>日本<>印度<>其他176個國家

領先的產業經濟學家：全球產業分析師知識庫追蹤了 14,949 位經濟學家，其中包括來自民族國家、智庫、貿易和產業協會、大型企業以及各領域專家的最具影響力的首席經濟學家，他們共用了這場前所未有的全球經濟狀況模式轉移的影響。我們超過 16,491 份報告大多遵循基於里程碑的兩階段發布計劃。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP34706

Global Bio-pharma Logistics Market to Reach US$172.9 Billion by 2030

The global market for Bio-pharma Logistics estimated at US$109.6 Billion in the year 2024, is expected to reach US$172.9 Billion by 2030, growing at a CAGR of 7.9% over the analysis period 2024-2030. Cold Chain Logistics, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$104.2 Billion by the end of the analysis period. Growth in the Non-Cold Chain Logistics segment is estimated at 10.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$28.8 Billion While China is Forecast to Grow at 7.7% CAGR

The Bio-pharma Logistics market in the U.S. is estimated at US$28.8 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$27.8 Billion by the year 2030 trailing a CAGR of 7.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.0% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.5% CAGR.

Global Bio-pharma Logistics Market - Key Trends & Drivers Summarized

Why Is Bio-pharma Logistics Emerging as a Strategic Pillar for Product Integrity, Cold Chain Compliance, and Global Therapeutic Reach?

Bio-pharma logistics has evolved into a mission-critical function within the life sciences value chain, underpinning the secure, timely, and temperature-controlled distribution of high-value pharmaceuticals, biologics, vaccines, and cell and gene therapies. With increasing product complexity and sensitivity, logistics now plays a central role in safeguarding therapeutic efficacy, regulatory compliance, and market access. From first-mile API transport to last-mile clinical delivery, logistics providers are being integrated into broader commercialization and supply continuity strategies.

The rise of temperature-sensitive biologics-including monoclonal antibodies, mRNA vaccines, and CAR-T therapies-has amplified the importance of end-to-end cold chain logistics. These products require stringent temperature ranges (typically 2-8°C, -20°C, or even cryogenic storage at -80°C) and must be monitored in real time to prevent thermal excursions that can compromise product viability. The expansion of decentralized clinical trials, direct-to-patient delivery models, and global vaccine programs has placed further demands on logistics infrastructure, visibility, and traceability.

Beyond temperature control, bio-pharma logistics must address challenges related to product shelf life, regulatory harmonization, customs clearance, and security in transit. With biologics and advanced therapies commanding high economic and therapeutic value, any disruption in the logistics chain can have far-reaching clinical and financial consequences. As a result, pharmaceutical companies are re-evaluating logistics as a strategic capability-selecting partners not just on cost but on quality assurance, compliance strength, and technological readiness.

How Are Cold Chain Technologies, Real-Time Visibility, and Risk Mitigation Strategies Reshaping Logistics Capabilities in Bio-pharma?

Cold chain innovation is at the forefront of logistics transformation. Advanced packaging solutions-such as phase-change materials, vacuum-insulated panels, and reusable thermal shippers-are being deployed to maintain temperature integrity over extended transit times and varied climatic conditions. Cryogenic containers with dry vapor nitrogen technology are increasingly used for cell and gene therapy shipments, where ultra-low temperature stability is non-negotiable.

Real-time visibility tools are becoming standard across critical lanes, with IoT-enabled data loggers, GPS trackers, and cloud-based dashboards providing granular insights into location, temperature, shock, light, and humidity. These tools allow logistics managers to intervene proactively in case of deviations, reroute sensitive shipments, and maintain audit trails for regulatory documentation. Integration with warehouse management systems (WMS), transport management systems (TMS), and blockchain-based platforms further enhances traceability and chain-of-custody assurance.

Risk mitigation is a key priority in bio-pharma logistics, particularly in high-risk geographies or during pandemic-level disruptions. Contingency planning, route qualification, dual-vendor cold chain setups, and redundant storage nodes are increasingly embedded in logistics strategies to ensure continuity of supply. Regulatory agencies such as the FDA, EMA, and WHO are mandating stricter controls on transport validation, temperature mapping, and deviation response protocols-reinforcing the need for logistics partners with GxP-compliant operations and pharmaceutical-grade quality systems.

Which Therapeutic Segments, Global Distribution Networks, and Strategic Partnerships Are Driving Demand for Specialized Bio-pharma Logistics?

Advanced therapies-including cell and gene therapies, personalized cancer vaccines, and RNA-based biologics-are the primary growth drivers in the bio-pharma logistics market. These therapies often have narrow windows of viability, require just-in-time delivery models, and are produced in centralized facilities with global patient bases. The surge in clinical trials across immuno-oncology, rare diseases, and next-generation vaccines is further increasing the volume and complexity of biologics moving through the logistics chain.

Global distribution networks are adapting to meet demand from emerging bio-clusters in Asia-Pacific, the Middle East, and Latin America, which are expanding manufacturing and clinical trial operations. Logistics hubs with GDP-certified facilities, regional cold storage, and multi-modal integration are being strategically established to reduce transit risk and enable faster time-to-therapy. North America and Western Europe remain central nodes, but decentralization and localization of manufacturing are prompting a shift toward more agile and distributed logistics architectures.

Strategic partnerships between pharma companies, 3PL providers, packaging vendors, and technology enablers are redefining the logistics ecosystem. Co-development of route validation protocols, shared risk models, and digital integration platforms is enabling end-to-end visibility and performance-based logistics management. As pharma manufacturers move toward leaner, demand-driven supply chains, logistics partners are being embedded earlier in planning cycles to co-design solutions tailored to specific therapy profiles and regulatory pathways.

What Are the Factors Driving Growth in the Bio-pharma Logistics Market?

The bio-pharma logistics market is expanding as the life sciences sector transitions toward complex, temperature-sensitive, and patient-centric therapies that demand high-precision, compliant logistics solutions. Logistics is now a critical enabler of therapeutic success, patient safety, and commercial scalability.

Key growth drivers include the proliferation of cold chain-dependent biologics and advanced therapies, expanding global clinical trials, regulatory mandates for end-to-end visibility, and rising demand for decentralized, agile delivery models. Technological innovation, strategic outsourcing, and vertically integrated service models are further accelerating market evolution.

As biopharma pipelines shift toward individualized, high-value therapeutics, could logistics become the competitive differentiator-transforming from a backend function into a value-generating, risk-mitigating, and innovation-aligned pillar of next-generation pharmaceutical delivery?

SCOPE OF STUDY:

The report analyzes the Bio-pharma Logistics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Cold Chain Logistics, Non-Cold Chain Logistics); Service Type (Transportation, Warehousing, Packaging, Other Service Types); Application (Biologics, Prescribed Drugs, Over-the-Counter Medicines, Raw Materials & Bulk Pharmaceuticals, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Agility Logistics
  • Air Canada Cargo
  • AmerisourceBergen Corporation
  • Biocair
  • Cavalier Logistics
  • CEVA Logistics
  • DB Schenker
  • DHL Global Forwarding
  • FedEx Corporation
  • Kerry Logistics Network Limited
  • Kuehne + Nagel
  • LifeConEx
  • Marken (a UPS Company)
  • Nippon Express
  • SF Express
  • Sofrigam Group
  • United Parcel Service (UPS)
  • VersaCold Logistics Services
  • World Courier
  • Yusen Logistics

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Bio-pharma Logistics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Demand for Temperature-Sensitive Biologics Throws the Spotlight on Specialized Bio-Pharma Logistics
    • Growth in Cell and Gene Therapy Markets Spurs Investment in Ultra-Cold Chain and Cryogenic Transportation
    • OEM Integration of Real-Time Monitoring and GPS Tracking Technologies Enhances Shipment Visibility and Integrity
    • Expansion of Just-in-Time Manufacturing and Direct-to-Patient Delivery Models Fuels Demand for Agile Logistics
    • OEM Focus on Lane Qualification, Regulatory Compliance, and GDP Certification Strengthens Provider Credibility
    • Growth in Biologics and Clinical Trial Logistics Drives Need for Time-Critical, High-Compliance Transport Networks
    • Adoption of Blockchain and Data Logging Solutions Enhances Chain-of-Custody Verification
    • Strategic Placement of Biopharma Logistics Hubs Near Manufacturing and Clinical Trial Centers Improves Responsiveness
    • Rise of Biopharma Outsourcing and Global CDMO Partnerships Supports 3PL and 4PL Market Expansion
    • Investment in Reverse Logistics and Packaging Reusability Supports Sustainability Goals in Pharmaceutical Transport
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Bio-pharma Logistics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Bio-pharma Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Bio-pharma Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Bio-pharma Logistics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Cold Chain Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Cold Chain Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Cold Chain Logistics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Non-Cold Chain Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Non-Cold Chain Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Non-Cold Chain Logistics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Raw Materials & Bulk Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Raw Materials & Bulk Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Raw Materials & Bulk Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Biologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Biologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Biologics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Prescribed Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Prescribed Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Prescribed Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Over-the-Counter Medicines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Over-the-Counter Medicines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Over-the-Counter Medicines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Transportation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Transportation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Transportation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Warehousing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Warehousing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Warehousing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Packaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Packaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Packaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Other Service Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Other Service Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Other Service Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Bio-pharma Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • JAPAN
    • Bio-pharma Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • CHINA
    • Bio-pharma Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • EUROPE
    • Bio-pharma Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Bio-pharma Logistics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Bio-pharma Logistics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Bio-pharma Logistics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • FRANCE
    • Bio-pharma Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • GERMANY
    • Bio-pharma Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Bio-pharma Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Europe 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Europe 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Europe 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Bio-pharma Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Asia-Pacific 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Asia-Pacific 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Asia-Pacific 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of World 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of World 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of World 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030

IV. COMPETITION